The Association Between BMI and Inpatient Mortality Outcomes in Older Adults With COVID-19

Akwe Nyabera1, Sofia Lakhdar1, Matthew Li2

  • 1Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA.

Cureus
|December 3, 2020
PubMed

Insights

In older adults with COVID-19, body mass index (BMI) did not predict hospital mortality. However, advanced age (≥85) increased mortality risk, while lower BMI (≤25) was linked to reduced need for mechanical ventilation.

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) presents a wide range of illness severity.
  • Obesity is linked to increased COVID-19 severity in younger adults.
  • Limited data exists on body mass index (BMI) and COVID-19 mortality in older adults (age >65).

Purpose of the Study:

  • To investigate the relationship between BMI and COVID-19 outcomes in older adults.
  • To identify predictors of hospital mortality and mechanical ventilation needs in this population.

Main Methods:

  • Single-center retrospective cohort study.
  • Included older adults (age >65) diagnosed with COVID-19.
  • Primary outcome: hospital mortality. Secondary outcomes: oxygen use, mechanical ventilation, length of stay. Analyzed using t-tests, Fisher's exact test, and logistic regression.

Main Results:

  • 290 older adults (mean age 77.6 years) with a median BMI >30 kg/m2 were studied.
  • Hospital mortality was 49.7%; BMI was not a predictor of mortality.
  • Age 75-79 and ≥85 years increased mortality risk. Lower BMI (≤25) and age ≥85 reduced the likelihood of requiring mechanical ventilation.

Conclusions:

  • In older adults with COVID-19, BMI is not an independent predictor of in-hospital mortality.
  • Advanced age (≥85) is associated with higher mortality risk.
  • Lower BMI (≤25) and advanced age (≥85) correlate with a decreased need for mechanical ventilation.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
946
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
91
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.0K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
415
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
118